MD3592G2 - Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin - Google Patents

Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin

Info

Publication number
MD3592G2
MD3592G2 MDA20070302A MD20070302A MD3592G2 MD 3592 G2 MD3592 G2 MD 3592G2 MD A20070302 A MDA20070302 A MD A20070302A MD 20070302 A MD20070302 A MD 20070302A MD 3592 G2 MD3592 G2 MD 3592G2
Authority
MD
Moldova
Prior art keywords
preparation
uterotonic
hysteromyoma
case
treating uterine
Prior art date
Application number
MDA20070302A
Other languages
English (en)
Russian (ru)
Other versions
MD3592F1 (ro
Inventor
Виктор ГИКАВЫЙ
Рафаэль Баркан
Original Assignee
Рафаэль Баркан
Виктор ГИКАВЫЙ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рафаэль Баркан, Виктор ГИКАВЫЙ filed Critical Рафаэль Баркан
Priority to MDA20070302A priority Critical patent/MD3592G2/ro
Publication of MD3592F1 publication Critical patent/MD3592F1/ro
Priority to PCT/IL2008/001466 priority patent/WO2009060451A2/en
Priority to EP08846478.9A priority patent/EP2219447B1/en
Priority to CN200880123695.5A priority patent/CN101917848B/zh
Priority to UAA201006063A priority patent/UA104847C2/uk
Priority to EA201000732A priority patent/EA030035B1/ru
Priority to US12/741,759 priority patent/US20100305210A1/en
Publication of MD3592G2 publication Critical patent/MD3592G2/ro
Priority to IL205535A priority patent/IL205535A/en
Priority to US16/944,137 priority patent/US12011423B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la medicină, în special la farmacologie şi ginecologie.Esenţa invenţiei constă în utilizarea dietilfosfatului de S-etilizotiouroniu în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin.Rezultatul invenţiei constă în aceea că la utilizarea locală a acestui preparat medicamentos în 88% cazuri se obţine o hemostază completă într-un termen redus şi fără efecte adverse.
MDA20070302A 2007-11-06 2007-11-06 Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin MD3592G2 (ro)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MDA20070302A MD3592G2 (ro) 2007-11-06 2007-11-06 Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin
PCT/IL2008/001466 WO2009060451A2 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EP08846478.9A EP2219447B1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
CN200880123695.5A CN101917848B (zh) 2007-11-06 2008-11-06 用于治疗子宫收缩过强病症的s-烷基异硫脲衍生物
UAA201006063A UA104847C2 (uk) 2007-11-06 2008-11-06 Похідні s-алкілізотіоуронію для лікування розладів з гіперскорочуваністю матки
EA201000732A EA030035B1 (ru) 2007-11-06 2008-11-06 Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
US12/741,759 US20100305210A1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating abnormal uterine bleeding disorders
IL205535A IL205535A (en) 2007-11-06 2010-05-04 Alkylisothiouronium - s derivatives for the treatment of uterine contraction disorders
US16/944,137 US12011423B2 (en) 2007-11-06 2020-07-30 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070302A MD3592G2 (ro) 2007-11-06 2007-11-06 Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin

Publications (2)

Publication Number Publication Date
MD3592F1 MD3592F1 (ro) 2008-05-31
MD3592G2 true MD3592G2 (ro) 2008-12-31

Family

ID=39471731

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070302A MD3592G2 (ro) 2007-11-06 2007-11-06 Preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin

Country Status (2)

Country Link
MD (1) MD3592G2 (ro)
UA (1) UA104847C2 (ro)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2323G2 (ro) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2323G2 (ro) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Paladi G. Ginecologie. Editura ARC, Chişinău, 1997, p. 133-140 *
Surcel V.I. Fibromiomul uterin. Editura Dacia, Cluj, 1998 *
Surcel V.I. Fibromiomul uterin. Editura Dacia, Cluj, 1998, p. 124 *
А.Ф. Диагностика и лечение дисфункциональных маточных *
Добротина А.Ф. Диагностика и лечение дисфункциональных маточных кровотечений. Медицина, 1978, p.221 *

Also Published As

Publication number Publication date
MD3592F1 (ro) 2008-05-31
UA104847C2 (uk) 2014-03-25

Similar Documents

Publication Publication Date Title
MX2020001513A (es) Agentes de union a clec9a y su uso.
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
WO2008129396A3 (en) Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
TW200605870A (en) Topical methadone compositions and methods for using the same
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
EP3974453A3 (en) Agents and methods for treating diseases that correlate with bcma expression
MX347525B (es) Inhibidores de tirosina cinasa de bruton.
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
GB2490084A (en) Methods and compositions to treat hemorrhagic conditions of the brain
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
PH12015500062A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MY173215A (en) Acetylcysteine compositions and methods of use thereof
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
AU316078S (en) Surgical tissue stimulator/locator
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
CA2899775C (en) Compositions and methods for pain relief without numbness
MX2020011817A (es) Metodos para tratar el linfoma.
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees